Axxess Pharma, a pharmaceutical company specialising in the marketing and distribution of both prescription and non-prescription medical products, is set to expand its product line with the addition of a new prescription drug, Fortex.
Subscribe to our email newsletter
Axxess Pharma said that Fortex drug is indicated for the relief of pain and inflammation of musculoskeletal conditions such as arthritis and muscle soreness.
As per a license agreement, Axxess Pharma is expected to have sole rights to manufacture and market the prescription drug in Canada.
Further, Fortex is expected to be prescribed by rheumatologists, orthopedic surgeons, general practitioners and pharmacists throughout Canada.
Additionally, in July 12, 2010, Axxess Pharma also informed about its signing of an exclusive license agreement to manufacture and distribute an FDA approved high potency cough and cold capsule in Canada and Middle East.
Axxess Pharma is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.